Safety and Antitumor Activity of the Usnic Acid Derivative OL9-116, a TDP1 Inhibitor, as an Adjunctive Therapy in Combination with Topotecan.
- DOI
- 10.3390/ijms27209266
- Published
- 2026-10-19
- Container
- Int J Mol Sci
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/ijms27209266,
title = {Safety and Antitumor Activity of the Usnic Acid Derivative OL9-116, a TDP1 Inhibitor, as an Adjunctive Therapy in Combination with Topotecan.},
author = {Kornienko TE and Zakharenko AL and Chernyshova IA and Chepanova AA and Dyrkheeva NS and Firsova AA and Rogachev AD and Luzina OA and Popova NA and Maksimova VP and Vlasova OA and Deryagina VP and Rodnyy AY and Salakhutdinov NF and Lavrik OI.},
year = {2026},
journal = {Int J Mol Sci},
doi = {10.3390/ijms27209266},
url = {https://doi.org/10.3390/ijms27209266}
}RIS
TY - JOUR TI - Safety and Antitumor Activity of the Usnic Acid Derivative OL9-116, a TDP1 Inhibitor, as an Adjunctive Therapy in Combination with Topotecan. AU - Kornienko TE AU - Zakharenko AL AU - Chernyshova IA AU - Chepanova AA AU - Dyrkheeva NS AU - Firsova AA AU - Rogachev AD AU - Luzina OA AU - Popova NA AU - Maksimova VP AU - Vlasova OA AU - Deryagina VP AU - Rodnyy AY AU - Salakhutdinov NF AU - Lavrik OI. PY - 2026 JO - Int J Mol Sci DO - 10.3390/ijms27209266 UR - https://doi.org/10.3390/ijms27209266 ER -
APA
TE, K., AL, Z., IA, C., AA, C., NS, D., AA, F., AD, R., OA, L., NA, P., VP, M., OA, V., VP, D., AY, R., NF, S., & OI., L. (2026). Safety and Antitumor Activity of the Usnic Acid Derivative OL9-116, a TDP1 Inhibitor, as an Adjunctive Therapy in Combination with Topotecan.. Int J Mol Sci. https://doi.org/10.3390/ijms27209266
Source records
- europe-pmc · retrieved 2026-11-10T09:04:33.213Z